Previous work supports a role for KDM5B in cultured breast cancer cell proliferation (Zhang et al., 2019), and its predicted inhibition in our dataset may represent a compensatory mechanism in response to sustained proliferative signaling by BPA alternative chemicals. This evidence concerns the gene KDM5B and breast carcinoma.